1. You are here:
  2. Research
  3. Research Articles
  4. 2024 Articles

2024 Articles

Accepted articles

Association of Official Racing Chemists guidelines for drug testing in animal hair for doping control.
Gray B, Bailly-Chouriberry L, Kwok WH, Yamada S, Yamada M, Moeller B.
Drug Test. Anal., DOI 10.1002/dta.3696.
Abstract

Pharmacokinetics of subcutaneous ketamine administration via the Omnipod® system in dogs.
Colón C, Early P, Muñana K, Olby N, Mariani C, Mancini S, Fefer G, Li Z, Briley J, Bailey K, Lascelles D, Messenger K.
J. Vet. Pharmacol. Ther., DOI 10.1111/jvp.13440.
Abstract

Endogenous nature of estra-4,9-diene-3,17-dione in entire male horses.
Ho HSM, Ho ENM, Wong WT.
Drug Test. Anal., DOI 10.1002/dta.3685.
Abstract

The effects of food on the pharmacokinetics of mycophenolate mofetil in healthy horses.
Bello K, Lorch G, Papich MG, Kim K, Toribio RE, Yan L, Xie Z, Hill K, Phelps MA.
J. Vet. Pharmacol. Ther., DOI 10.1111/jvp.13430.
Abstract

Comprehensive metabolic investigation of dopamine reuptake inhibitor HDMP-28 in equine liver microsomes and Cunninghamella elegans for doping control.
Muhammed Ajeebsanu M, Subhahar MB, Karakka Kal AK, Philip M, Perwad Z, Karatt TK, Graiban FM, Joseph M, Jose SV.
Drug Test. Anal., DOI 10.1002/dta.3642.
Abstract

Effect of clodronate on gene expression in the peripheral blood of horses.
Wilcox CV, Knych HK, Katzman SA, Arthur RM, Rodriguez V, Finno CJ.
J. Vet. Pharmacol. Ther., DOI 10.1111/jvp.13424.
Abstract

Detection of FG-4592 and metabolites in equine plasma, urine and hair following oral administration.
Cutler C, Viljanto M, Taylor P, Hincks P, Habershon-Butcher J, Gray B, Scarth J.
Drug Test. Anal., DOI 10.1002/dta.3643.
Abstract

Presence and detection of endogenous steroids in the horse—A review.
Viljanto M, Gray B, Scarth J.
Drug Test. Anal., DOI 10.1002/dta.3624.
Abstract

Published articles

Simultaneous determination of five compounds of fried Radix Paeoniae Alba extract in beagle dogs plasma by ultra performance liquid chromatography tandem mass spectrometry and its application in a pharmacokinetic study.
Cheng W, Yuan Z, Wu S, Yu X, Xia K, Zhao L, Wang Y, Kang C, Yang W, Liu L, Li Y.
Biomed. Chromatogr., 2024, 38, e5803.
Abstract

Identification of the dermorphin tetrapeptide [Dmt1]-DALDA in a seized unlabelled vial and its first detection in horse urine: A case report.
Choi TLS, Lau MY, Wong JKY, Wan TSM, Ho ENM.
Drug Test. Anal., 2024, 16, 268-276.
Abstract

Cannabidiol and cannabidiolic acid: Preliminary in vitro evaluation of metabolism and drug-drug interactions involving canine cytochrome P-450, UDP-glucuronosyltransferase, and P-glycoprotein.
Court MH, Mealey KL, Burke NS, Jimenez TP, Zhu Z, Wakshlag JJ.
J. Vet. Pharmacol. Ther., 2024, 47, 1-13.
Abstract

Detection of doping peptides and basic drugs in equine urine using liquid chromatography-mass spectrometry.
Flores L, Hargrave S, Clifford A, Alarcio G, Moeller BC.
Drug Test. Anal., 2024, 16, 406-419.
Abstract

The effects of formulation on the pharmacokinetics of itraconazole and amiodarone in dogs after oral administration of a combination product, commercial products, and compounded products.
Hunter RP, Madigan R.
J. Vet. Pharmacol. Ther., 2024, 47, 65-72.
Abstract

Pharmacokinetic study of osilodrostat and identification of mono-hydroxylated metabolite in equine plasma for the purpose of doping control.
Ishii H, Ishikawa Y, Mizobe F, Nomura M, Yamanaka T, Tanabe S, Nagata SI, Yamada M, Leung GN.
Rapid Commun. Mass Spectrom., 2024, 38, e9695.
Abstract

Pharmacokinetics and tolerability of a veterinary phenobarbital product in healthy dogs.
Jukier T, Gross A, Boothe D.
Front. Vet. Sci., 2024, 10, 1307888.
Abstract

Ketoprofen in horses: Metabolism, pharmacokinetics, and effects on inflammatory biomarkers.
Knych HK, McKemie DS, Kass PH, Stanley SD, Blea J.
Drug Test. Anal., 2024, 16, 289-302.
Abstract

Evaluation of plasma and urine pharmacokinetics of tranexamic acid for equine medication control.
Minamijima Y, Kuroda T, Kamiya T, Sone Y, Wakuno A, Ito H, Nomura M, Leung GN, Kinoshita K, Yamada M.
J. Vet. Pharmacol. Ther., 2024, 47, 21-27.
Abstract

Stereoselective pharmacokinetics of ketamine administered at a low dose in awake dogs.
Pargätzi G, Bergadano A, Spadavecchia C, Theurillat R, Thormann W, Levionnois OL.
J. Vet. Pharmacol. Ther., 2024, 14, 1012.
Abstract

High-throughput untargeted screening of biotherapeutic macromolecules in equine plasma by UHPLC-HRMS/MS: Application to monoclonal antibodies and Fc-fusion proteins for doping control.
Pinetre J, Delcourt V, Becher F, Garcia P, Barnabé A, Loup B, Popot MA, Fenaille F, Bailly-Chouriberry L.
Drug Test. Anal., 2024, 16, 199-209.
Abstract

The pharmacokinetics and pharmacodynamics of fentanyl administered via transdermal patch in horses.
Reed RA, Berghaus LJ, Reynolds RM, Holmes BT, Krikorian AM, Sakai DM, Ishikawa Y, Knych HK.
Front. Pain Res. (Lausanne), 2024, 5, 1373759.
Abstract

Identification of erythropoietin mimetic peptide 1 linear form in a sealed vial and its administration study in horses for doping control purpose.
So YM, Wong JKY, Wong ASY, Tse ATL, Wan TSM, Ho ENM.
Drug Test. Anal., 2024, 16, 71-82.
Abstract

Doping control approach: Identification of equine in vitro metabolites of voxelotor (GBT440), a hemoglobin S polymerization inhibitor.
Subhahar MB, Karakka Kal AK, Philip M, Muhammed Ajeebsanu M, Karatt TK, Perwad Z.
Rapid Commun. Mass Spectrom., 2024, 38, e9671.
Abstract

Detection of boldenone in the urine of female horses-ex vivo formation versus administration.
Viljanto M, Kaabia Z, Taylor P, Hincks P, Muir T, Habershon-Butcher J, Bailly-Chouriberry L, Scarth J.
Drug Test. Anal., 2024, 16, 112-126.
Abstract

Herb-drug interactions of silybinin and cilofexor in beagle dogs based on pharmacokinetics by UPLC-MS/MS.
Wei X, Su Y, Cheng Q, Liang S, Zhang T, Duan L, Shen X, Qiu X.
Front. Pharmacol., 2024, 15, 1334402.
Abstract

PCR-based equine gene doping test for the Australian horseracing industry.
Wilkin T, Hamilton NA, Cawley AT, Bhat S, Baoutina A.
Int. J. Mol. Sci., 2024, 25, 2570.
Abstract

Screening and confirmation of recombinant human follistatin in equine plasma for doping control purposes.
Wong KS, Cheung HW, Choi YC, To NS, Wan TSM, Ho ENM.
Drug Test. Anal., 2024, 16, 259-267.
Abstract

Gene doping control analysis of human erythropoietin transgene in equine plasma by PCR-liquid chromatography high-resolution tandem mass spectrometry.
Yuen BP, Wong KS, So YM, Kwok WH, Cheung HW, Wan TSM, Ho EN, Wong WT.
Anal. Chem., 2024, 96, 5307-5314.
Abstract